At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 21 enrolled
Drug / intervention
Acetylsalicylic acid +1 moredrug
Likely dose
Acetylsalicylic acid 300 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Acetylsalicylic Acid Administered in Patients With Type 2 Diabetes Mellitus and Its Effect on the Antioxidant Enzyme System
Centro Universitario de Ciencias de la Salud, Mexico·interventional·Posted Nov 14, 2017·Updated Nov 14, 2017
In Brief
A Phase 3 clinical trial evaluating Acetylsalicylic acid and Calcined magnesia for Diabetes Mellitus, Type 2 and Antioxidant Enzyme System. Completed, enrolled 21 participants.
Detailed Summary
OBJETIVE To assess the effect of acetylsalicylic acid on antioxidant enzymatic system in patients with type 2 diabetes
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartDec 2014
Primary CompletionDec 2015
Study CompletionDec 2016
First PostedNov 2017
TodayJul 2026
First PostedNov 14, 2017
Enrollment StartDec 2, 2014
Primary CompletionDec 2, 2015
Study CompletionDec 2, 2016
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 8.6 years ago
Interventions
Acetylsalicylic aciddrug
Acetylsalicylic acid 300 mg per capsule
Calcined magnesiadrug
Calcined magnesia 300 mg per capsule